Media Center

While mild temperatures continue to sweep the nation well into October, city dwellers and communities across New England continue to spend days and nights outdoors. Increasingly, it is also the season for Lyme disease, a tick-borne illness that afflicts an estimated 476,000 people in the U.S. Children aged 5-14 years old have historically represented the largest share of confirmed cases, according to CDC data.

Decentralized trials have a new home in Sun City Center, Florida. On November 3, Care Access held a ribbon cutting ceremony for a new research site in the active living senior community. The Sun City Chamber of Commerce and local business leaders joined the Care Access team in celebrating the new research facility. It is the first in a network of purpose-built sites for an Alzheimer’s prevention study.

(BUSINESS WIRE) — Care Access, the world's leader in executing decentralized clinical trials at scale, has announced its upcoming involvement at four key industry conferences: CNS Summit, Outsourcing in Clinical Trials New England (OCTNE), Decentralized Trials & Research Alliance Annual Meeting (DTRA), and Decentralized Trials Digital Week.

(BUSINESS WIRE) -- Care Access, the world’s leading decentralized research organization (DRO), today announced its expanded partnership with global biopharma leader Eli Lilly and Company (Lilly) to broaden patient access to clinical trials and increase representation of minority group members, including African American, Hispanic, and LatinX populations.

Taking research sites directly to local communities may hold the key to decreasing patient burden. An estimated 70 percent of potential trial participants live over two hours away from the nearest research center, forcing many to think twice about enrolling in a clinical study.¹ Traveling to distant research sites can be time-consuming, costly and, in some cases, nearly impossible for certain patients due to health concerns, work and childcare responsibilities, and lack of access to transportation.